# Voriconazole

## Vfend inj 200mg

##### 臨採

| TAH Drug Code      | [IVFEN](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IVFEN)                                                                                                                                                                                                                                                      |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of invasive aspergillosis, candidemia in non-neutropenic patients, fluconazole-resistant serious invasive Candida infections (including C. krusei), esophageal candidiasis, serious fungal infections caused by Scedosporium spp & Fusarium spp in patients w/ progressive, possibly life-threatening infections. |
| Dosing             | (仿單+熱病) Loading dose is recommended. Adult and children (12-14 years and weighing > or = 50 kg, or 15-17 years): 6 mg/kg IV Q12H x 2 doses (loading), then 3-4 mg/kg IV Q12H. Children (2-12 years, or 12-14 years and weighing < 50 kg): 9 mg/kg IV Q12H x 2 doses, then 4-8 mg/kg IV Q12H.                                |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                    |
| Contraindications  | Co-administration w/ terfenadine, astemizole, cisapride, pimozide, quinidine, sirolimus, rifampicin, carbamazepine, long-acting barbiturates (eg phenobarb), ritonavir, ergot alkaloids (eg ergotamine & dihydroergotamine), St. John's wort                                                                                |
| Adverse Effects    | Headache, visual disturbances, nausea, vomiting, diarrhea, abdominal pain, rash, fever, peripheral edema.                                                                                                                                                                                                                   |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Risk                                                                                                                                                                                                                                                                          |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                |

